Skip to main content
Glama

Fda Device Company Profile

fda_device_company_profile
Read-onlyIdempotent

Build a bounded FDA regulatory snapshot for one device company across 510(k), PMA, recalls, and MAUDE. Dataset name matching is imperfect and MAUDE counts are signals, not safety rates.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
companyYesCompany/manufacturer name.
limit_per_datasetNoRows per dataset (1-20, default 5).

Output Schema

TableJSON Schema
NameRequiredDescriptionDefault
companyYes
recallsYes
maude_reportsYes
pma_decisionsYes
interpretationYes
clearances_510kYes

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.2/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint, and destructiveHint. The description adds important behavioral caveats: imperfect name matching and that MAUDE counts are signals, not safety rates, which provides context beyond annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Two sentences: first states core purpose, second adds key caveats. No wasted words, front-loaded with action.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a snapshot tool with output schema and clear annotations, the description covers purpose, datasets, and limitations. It could briefly mention how datasets are combined, but output schema likely provides structure.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with descriptions for both parameters. The description adds value by noting imperfect name matching for the 'company' parameter, implying fuzzy matching, which is not in the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the verb 'Build' and resource 'FDA regulatory snapshot for one device company' across specific datasets (510(k), PMA, recalls, MAUDE). It distinguishes from sibling tools like fda_device_510k_search by focusing on a multi-dataset overview.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines3/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description implies usage for an aggregated snapshot of one company, but does not explicitly state when not to use it or mention alternatives like individual dataset tools.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.